Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | AGXT | P21549 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4579423 | 0.83 | TAAR1 (0.50) | TAAR1AOC3ELOVL1PTGS1PTGS2 | |
| SCHEMBL17070611 | 0.83 | TAAR1 (0.50) | TAAR1AOC3ELOVL1PTGS1PTGS2 | |
| SCHEMBL28367193 | 0.83 | TAAR1 (0.54) | TAAR1AOC3ELOVL1PTGS1PTGS2 | |
| SCHEMBL15114792 | 0.82 | KCNH2 (0.50) | TAAR1IDO1AGXTMAPTKMT2A | |
| SCHEMBL15114763 | 0.80 | ESR1 (0.50) | TAAR1PTGS1PTGS2KDM4EMAPT | |
| SCHEMBL2172552 | 0.80 | TAAR1 (0.44) | TAAR1MAOBIDO1KDM4EMEN1 | |
| SCHEMBL27756949 | 0.80 | TAAR1 (0.53) | TAAR1AOC3MAOBIDO1AGXT | |
| SCHEMBL27756950 | 0.80 | CHKA (0.36) | — | |
| SCHEMBL8401100 | 0.79 | CA1 (0.42) | TAAR1IDO1KDM4EL3MBTL1 | |
| SCHEMBL17662689 | 0.79 | RAB9A (0.49) | TAAR1AOC3ELOVL1PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713320-A2 | BCAT2 INHIBITORS | Agios Pharmaceuticals, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024238820-A2 | BCAT2 INHIBITORS | AGIOS PHARMACEUTICALS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |